Literature DB >> 23703691

[Kaplan-Meier analysis in urological practice].

M Rink1, L A Kluth, S F Shariat, M Fisch, R Dahlem, P Dahm.   

Abstract

Kaplan-Meier curves and estimates of survival are the most common way to present survival data in medicine, especially for cohorts with different lengths of follow-up. Moreover, Kaplan-Meier curves present a frequently used general graphic approach to display time-to-event outcomes. A solid understanding of how Kaplan-Meier curves are generated and how they should be analyzed and interpreted is of great importance to appraise urological literature in daily clinical practice. This article describes the basic principles of Kaplan-Meier analysis, possible variants and pitfalls. Improved knowledge of Kaplan-Meier analysis can help to improve Evidence-based urology and its application in patient care.

Entities:  

Mesh:

Year:  2013        PMID: 23703691     DOI: 10.1007/s00120-013-3150-4

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  10 in total

Review 1.  Evaluating health outcomes in the presence of competing risks: a review of statistical methods and clinical applications.

Authors:  Ravi Varadhan; Carlos O Weiss; Jodi B Segal; Albert W Wu; Daniel Scharfstein; Cynthia Boyd
Journal:  Med Care       Date:  2010-06       Impact factor: 2.983

2.  Evidence-based urology in practice: Kaplan-Meier analysis.

Authors:  Roger L Sur; Philipp Dahm
Journal:  BJU Int       Date:  2010-03-11       Impact factor: 5.588

Review 3.  A practical guide to understanding Kaplan-Meier curves.

Authors:  Jason T Rich; J Gail Neely; Randal C Paniello; Courtney C J Voelker; Brian Nussenbaum; Eric W Wang
Journal:  Otolaryngol Head Neck Surg       Date:  2010-09       Impact factor: 3.497

4.  Inadequate statistical power of negative clinical trials in urological literature.

Authors:  Rodney H Breau; Toby A Carnat; Isabelle Gaboury
Journal:  J Urol       Date:  2006-07       Impact factor: 7.450

Review 5.  Interpreting statistics in the urological literature.

Authors:  Charles D Scales; Bercedis Peterson; Philipp Dahm
Journal:  J Urol       Date:  2006-11       Impact factor: 7.450

Review 6.  Survival probabilities (the Kaplan-Meier method).

Authors:  J M Bland; D G Altman
Journal:  BMJ       Date:  1998-12-05

7.  [Confidence intervals and p-values in urology: interpretation and misinterpretation].

Authors:  M Rink; L A Kluth; S F Shariat; R Dahlem; M Fisch; P Dahm
Journal:  Urologe A       Date:  2013-04       Impact factor: 0.639

8.  [Use of PubMed to improve evidence-based medicine in routine urological practice].

Authors:  M Rink; L A Kluth; S F Shariat; F K Chun; M Fisch; P Dahm
Journal:  Urologe A       Date:  2013-03       Impact factor: 0.639

9.  Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy.

Authors:  Marco Roscigno; Shahrokh F Shariat; Vitaly Margulis; Pierre Karakiewicz; Mesut Remzi; Eiji Kikuchi; Cord Langner; Yair Lotan; Alon Weizer; Karim Bensalah; Jay D Raman; Christian Bolenz; Charles C Guo; Christopher G Wood; Richard Zigeuner; Jeffrey Wheat; Wareef Kabbani; Theresa M Koppie; Casey K Ng; Nazareno Suardi; Roberto Bertini; Mario I Fernández; Shuji Mikami; Masaru Isida; Maurice Stephan Michel; Francesco Montorsi
Journal:  J Urol       Date:  2009-04-16       Impact factor: 7.450

10.  Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial.

Authors:  Ian M Thompson; Catherine M Tangen; Jorge Paradelo; M Scott Lucia; Gary Miller; Dean Troyer; Edward Messing; Jeffrey Forman; Joseph Chin; Gregory Swanson; Edith Canby-Hagino; E David Crawford
Journal:  J Urol       Date:  2009-01-23       Impact factor: 7.450

  10 in total
  2 in total

1.  Prognostic impact of paraneoplastic syndromes on patients with non-metastatic renal cell carcinoma undergoing surgery: Results from Canadian Kidney Cancer information system.

Authors:  Ryan Sun; Rodney H Breau; Ranjeeta Mallick; Simon Tanguay; Frederic Pouliot; Anil Kapoor; Luke T Lavallée; Antonio Finelli; Alan I So; Ricardo A Rendon; Adrian S Fairey; Jean-Baptiste Lattouf; Jun Kawakami; Bimal Bhindi; Naveen S Basappa; Lori A Wood; Georg A Bjarnason; Daniel Y C Heng; Rahul K Bansal
Journal:  Can Urol Assoc J       Date:  2021-04       Impact factor: 1.862

2.  Impact of the Ki-67 labeling index and p53 expression status on disease-free survival in pT1 urothelial carcinoma of the bladder.

Authors:  Malte W Vetterlein; Julia Roschinski; Philipp Gild; Phillip Marks; Armin Soave; Ousman Doh; Hendrik Isbarn; Wolfgang Höppner; Walter Wagner; Shahrokh F Shariat; Maurizio Brausi; Franziska Büscheck; Guido Sauter; Margit Fisch; Michael Rink
Journal:  Transl Androl Urol       Date:  2017-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.